Page 2 - Walter and Eliza Hall Institute of Medical Research

Medical research

Resistance-fighting antimalarial drug candidate enters the clinic

A new antimalarial drug candidate, discovered through a longstanding collaboration between WEHI and global biopharmaceutical company MSD has entered Phase 1 clinical testing in healthy participants. The candidate drug inhibits ...

Diseases, Conditions, Syndromes

Surprise discovery redirects efforts for treatment of liver disease

WEHI researchers have revealed that common liver diseases are not driven by inflammatory cell death as previously thought, resolving a long-standing controversy in gastroenterology and pointing to a new direction for treatment.

page 2 from 11